US 3193460A
· Krabbe et al.
· 1965
[cited by applicant]
US 3905865A
· Mcaleer et al.
· 1975
[cited by applicant]
US 4080258A
· McAleer et al.
· 1978
[cited by applicant]
US 4343904A
· Birch et al.
· 1982
[cited by applicant]
US 4379846A
· Shkidchenko et al.
· 1983
[cited by applicant]
US 4508819A
· Rose
· 1985
[cited by applicant]
US 4904600A
· Ramp
· 1990
[cited by applicant]
US 5266476A
· Sussman et al.
· 1993
[cited by applicant]
US 5320963A
· Knaack et al.
· 1994
[cited by applicant]
US 5585266A
· Plitt et al.
· 1996
[cited by applicant]
US 5650325A
· Spielmann
· 1997
[cited by applicant]
US 5656421A
· Gebhard et al.
· 1997
[cited by applicant]
US 5705390A
· Kadouri et al.
· 1998
[cited by applicant]
US 5786215A
· Brown et al.
· 1998
[cited by applicant]
US 6197575B1
· Griffith et al.
· 2001
[cited by applicant]
US 6835390B1
· Vein
· 2004
[cited by applicant]
US 7875448B2
· Furey
· 2011
[cited by applicant]
US 8294632B2
· Skarp
· 2012
[cited by applicant]
US 9023642B2
· Kleis et al.
· 2015
[cited by applicant]
US 9249383B2
· Yu et al.
· 2016
[cited by applicant]
US 9657266B2
· Kasuto et al.
· 2017
[cited by applicant]
US 9969966B2
· Asgari
· 2018
[cited by applicant]
US 9994812B2
· Kim et al.
· 2018
[cited by applicant]
US 20050084958A1
· Vein
· 2005
[cited by applicant]
US 20050095711A1
· More
· 2005
[cited by applicant]
US 20060172417A1
· Rathenow et al.
· 2006
[cited by applicant]
US 20070122901A1
· Morita et al.
· 2007
[cited by applicant]
US 20080009063A1
· Okano et al.
· 2008
[cited by applicant]
US 20080206735A1
· Asgari
· 2008
[cited by applicant]
US 20080208351A1
· Besenbacher et al.
· 2008
[cited by applicant]
US 20090311777A1
· Edwards et al.
· 2009
[cited by applicant]
US 20100184182A1
· Hase
· 2010
[cited by applicant]
US 20100196432A1
· Feinberg et al.
· 2010
[cited by applicant]
US 20100216242A1
· Shimizu et al.
· 2010
[cited by applicant]
US 20110195462A1
· Banks
· 2011
[cited by applicant]
US 20110212493A1
· Hirschel et al.
· 2011
[cited by applicant]
US 20130196375A1
· Strobbe
· 2013
[cited by applicant]
US 20150322397A1
· Cornforth
· 2015
[cited by examiner]
US 20160251625A1
· Genovese et al.
· 2016
[cited by applicant]
US 20170253849A1
· Miller
· 2017
[cited by applicant]
US 20180214600A1
· Magin et al.
· 2018
[cited by applicant]
US 20190024079A1
· Genovese et al.
· 2019
[cited by applicant]
US 20190213519A1
· Metz et al.
· 2019
[cited by applicant]
US 20210130760A1
· Castillo et al.
· 2021
[cited by applicant]
US 20210171912A1
· Genovese et al.
· 2021
[cited by applicant]
US 20210403848A1
· Tsuzuki et al.
· 2021
[cited by applicant]
US 20220195359A1
· Lavon et al.
· 2022
[cited by applicant]
US 20220213427A1
· Melchiorri
· 2022
[cited by applicant]
US 20220396756A1
· Mouthuy
· 2022
[cited by applicant]
US 20230407224A1
· Lavon et al.
· 2023
[cited by applicant]
CN 1350433A
· 2002
[cited by applicant]
CN 101132803A
· 2008
[cited by applicant]
CN 101646762A
· 2010
[cited by applicant]
CN 102232109A
· 2011
[cited by applicant]
CN 103747693A
· 2014
[cited by applicant]
CN 108025112A
· 2018
[cited by applicant]
CN 108697119A
· 2018
[cited by applicant]
CN 109154006A
· 2019
[cited by applicant]
DE 102008015633A1
· 2009
[cited by applicant]
EP 2736357B1
· 2014
[cited by applicant]
JP S62087092A
· 1987
[cited by applicant]
JP 2005080540A
· 2005
[cited by applicant]
JP 2008011766A
· 2008
[cited by applicant]
JP 2010161954A
· 2010
[cited by applicant]
JP 2017176140A
· 2017
[cited by applicant]
JP 62044173A
· 2017
[cited by applicant]
JP 2019213519A
· 2019
[cited by applicant]
JP 2022554013A
· 2022
[cited by applicant]
KR 1020140040212A
· 2014
[cited by applicant]
KR 1020180026792A
· 2018
[cited by applicant]
KR 1020180096947A
· 2018
[cited by applicant]
TW 92112990
· 2003
[cited by applicant]
WO 8800235
· 1988
[cited by applicant]
WO 9931222
· 1999
[cited by applicant]
WO 2006041429A2
· 2006
[cited by applicant]
WO 2014036187A1
· 2014
[cited by applicant]
WO WO2014141136A1
· 2014
[cited by applicant]
WO 2015073918A1
· 2015
[cited by applicant]
WO 2017019970A1
· 2017
[cited by applicant]
WO 2018011805A2
· 2018
[cited by applicant]
WO 2019014652A1
· 2019
[cited by applicant]
WO 2019122239A1
· 2019
[cited by applicant]
WO 2020243324A1
· 2020
[cited by applicant]
WO 2021102375A1
· 2021
[cited by applicant]
WO 2021108093A1
· 2021
[cited by applicant]
WO 2021108094A1
· 2021
[cited by applicant]
WO WO2022036371A1
· 2022
[cited by examiner]
Examination Report as received in Australian application 2023200307 dated Oct. 8, 2024.
[cited by applicant]
Office Action as received in Canadian application 3,219,264 dated Sep. 18, 2024.
[cited by applicant]
Office Action as received in Mexican application MX/a/2022/006095 dated Oct. 4, 2024.
[cited by applicant]
Search Report and Written Opinion as received in SG Application No. 10202402267S dated Oct. 15, 2024.
[cited by applicant]
U.S. Appl. No. 18/439,503 filed Oct. 11, 2024.
[cited by applicant]
Examination Report as received in Australian application 2022203772 dated Feb. 28, 2024.
[cited by applicant]
Office Action as received in Japanese application 2024-045237 dated May 29, 2024.
[cited by applicant]
Examination Report as received in Australian application 2023200307 dated Jun. 21, 2024.
[cited by applicant]
Examination Report as received in Australian application 2022203772 dated Jun. 24, 2024.
[cited by applicant]
Office Action as received in KR application 10-2024-7009465 dated Jun. 25, 2024.
[cited by applicant]
Notice of Eligibility for Grant and Examination Report as received in SG application 11202113006V dated Jul. 1, 2024.
[cited by applicant]
U.S. Appl. No. 18/439,503, May 29, 2024, Office Action.
[cited by applicant]
Examination Report as received in Australian application 2023200307 dated Feb. 7, 2025.
[cited by applicant]
EPO Communication pursuant to Article 94(3) as received in application 20834000.0 dated Dec. 3, 2024.
[cited by applicant]
Notice of Allowance as received in JP application 2024-045237 dated Jan. 17, 2025.
[cited by applicant]
Notice of Allowance as received in KR application 10-2024-7009465 dated Dec. 13, 2024.
[cited by applicant]
Search Report as received in Taiwanese application 113101738 dated Dec. 23, 2024.
[cited by applicant]
U.S. Appl. No. 17/558,243, Jan. 14, 2025, Office Action.
[cited by applicant]
International Search Report and Written Opinion mailed on Nov. 9, 2020, in International Application No. PCT/US2020/034949, 15 pages.
[cited by applicant]
International Search Report and Written Opinion mailed on Mar. 12, 2021, in International Application No. PCT/US2020/061676, 13 pages.
[cited by applicant]
International Search Report & Written Opinion as received in PCT/US 22/78310 dated Feb. 21, 2023.
[cited by applicant]
Acevedo et al., “Micropatterning Technology to Design an Edible Film for In Vitro Meat Production”, Food and Bioprocess Technology, vol. 11, No. 7, Mar. 25, 2018, pp. 1267-1273.
[cited by applicant]
Bhat et al., Prospectus of cultured meat-advancing meat alternatives, Journal of Food Science and Technology, vol. 48, No. 2, Dec. 30, 2010, pp. 125-140.
[cited by applicant]
Brunette, “Fibroblasts on micromachined substrata orient hierarchically to grooves of different dimensions,” Exp Cell Res. 1986; 164(1):11-26.
[cited by applicant]
Brunette, “Spreading and orientation of epithelial cells on grooved substrata,” Exp Cell Res. 1986; 167(1):203-217.
[cited by applicant]
Clark et al., “Topographical control of cell behaviour: II. multiple grooved substrata,” Development 108, 635-644 (1990).
[cited by applicant]
Datar et al., “Possibilities for an in vitro meat production system,” Innovative Food Science and Emerging Technologies, vol. 11, No. 1, Jan. 1, 2010, pp. 13-22.
[cited by applicant]
Gaydhane et al., “Cultured meat: state of the art and future,” Biomanufacturing Reviews, vol. 3, No. 1, Mar. 19, 2018.
[cited by applicant]
Karuri et al., “Biological length scale topography enhances cell-substratum adhesion of human corneal epithelial cells,” J Cell Sci. 2004; 117: 3153-3164.
[cited by applicant]
Lam et al., “Microfeature guided skeletal muscle tissue engineering for highly organized 3-dimensional free-standing constructs”, Biomaterials, vol. 30, No. 6, Feb. 1, 2009, pp. 1150-1155.
[cited by applicant]
Ostrovidov et al., “Skeletal Muscle Tissue Engineering: Methods to Form Skeletal Myotubes and Their Applications” Tissue Engineering: Part B, vol. 20, No. 5, Oct. 1, 2014 (Oct. 1, 2014), pp. 403-436.
[cited by applicant]
Riboldi et al., “Electrospun degradable polyesterurethane membranes: potential scaffolds for skeletal muscle tissue engineering,” Biomaterials, vol. 26, No. 22, 1August 2005, pp. 4606-4615.
[cited by applicant]
Hosseini et al. “Engineered contractile skeletal muscle tissue on a microgrooved methacrylated gelatin substrate.” Tissue Eng Part A. Dec. 2012;18(23-24):2453-65. (Year: 2012).
[cited by applicant]
Bajaj et al. “Patterning the differentiation of C2C12 skeletal nnyoblasts.” Integrative Biology, vol. 3, Issue 9, Sep. 2011, pp. 897-909 (Year: 2011).
[cited by applicant]
Cha et al. “Study of myoblast differentiation using multi-dimensional scaffolds consisting of nano and micropatterns.” Biomater Res .Jan. 11, 2017;21:1. (Year: 2017).
[cited by applicant]
Charest et al. “Myoblast alignment and differentiation on cell culture substrates with microscale topography and model chemistries.” Biomaterials.Apr. 2007;28(13):2202-10. (Year: 2007).
[cited by applicant]
Zeng et al. “A minimally invasive method for retrieving single adherent cells of different types from cultures”, Sci Rep .Jun. 24, 2014;4:5424. (Year: 2014).
[cited by applicant]
Willem Visser et al. “Quantifying Cell Adhesion through Impingement of a Controlled Microjet.”Biophys J. Jan. 6, 2015; 108(1): 23-31. (Year: 2015).
[cited by applicant]
“What is Fluid Mechanics.” Mechanical Engineering. Penn State College of Engineering. Retrieved on Dec. 1, 2021. Retrieved from https://www.rne.psu.eduicinnbala/Learning/Fluid/Introductory/what is fluid rnechanics.htm (…
[cited by applicant]
Examination Report as received in Australian application 2020284005 dated May 2, 2022.
[cited by applicant]
Examination Report as received in Australian application 2022241490 dated Nov. 3, 2022.
[cited by applicant]
Examination Report as received in Australian application 2022241490 dated Jan. 25, 2023.
[cited by applicant]
Office Action as received in Canadian application 3,141,870 dated Jun. 3, 2022.
[cited by applicant]
Office Action as received in Canadian application 3,160,109 dated Sep. 15, 2022.
[cited by applicant]
Notice of Allowance as received in Canadian application 3,201,964 dated Jul. 18, 2023.
[cited by applicant]
Notice of Allowance as received in Canadian application 3,201,964 dated Aug. 30, 2023.
[cited by applicant]
Notice of Allowance as received in CA application 3,210,518 dated Nov. 21, 2023.
[cited by applicant]
Conditional Notice of Allowance as received in Canadian application 3,198,589 dated Sep. 5, 2023.
[cited by applicant]
Office Action as received in Chinese application 202080080154.X dated Jan. 3, 2023.
[cited by applicant]
Office Action as received in Chinese application 202080080154.X dated May 7, 2023.
[cited by applicant]
Office Action as received in CN application 202080080154.X dated Nov. 7, 2023.
[cited by applicant]
Office Action as received in Chinese application 202080049214.1 dated Jul. 15, 2022 [No English translation available].
[cited by applicant]
Office Action as received in Chinese application 202080049214.1 dated Jan. 20, 2023 [No English translation available].
[cited by applicant]
Office Action as received in Chinese application 202080049214.1 dated May 16, 2023.
[cited by applicant]
Office Action as received in Chinese application 2023116995466 dated Apr. 25, 2024.
[cited by applicant]
Office Action as received in Chinese application 2023117065159 dated Apr. 15, 2024.
[cited by applicant]
EPO Communication pursuant to Article 94(3) as received in application 20745342.4 dated Feb. 28, 2024.
[cited by applicant]
Office Action as received in European application 20745342.4 dated Dec. 9, 2021.
[cited by applicant]
Office Action as received in European application 20834000.0 dated Jun. 10, 2022.
[cited by applicant]
Office Action as received in Japanese application 2022-525657 dated Oct. 31, 2022 [No English translation available].
[cited by applicant]
Office Action as received in Japanese application 2022-525657 dated Apr. 21, 2022.
[cited by applicant]
Notice of Allowance as received in Japanese application 2022-525657 dated Jul. 24, 2023.
[cited by applicant]
Office Action as received in JP application 2023-133508 dated Oct. 27, 2023.
[cited by applicant]
Notice of Allowance as received in JP application 2023-133508 dated Feb. 26, 2024.
[cited by applicant]
Office Action as received in Israeli application 288338 dated May 25, 2022.
[cited by applicant]
Office Action as received in Israeli application 296327 dated Mar. 23, 2023.
[cited by applicant]
Notice of Allowance as received in IL application 304043 dated Dec. 12, 2023.
[cited by applicant]
Office Action as received in IL application 304041 dated Nov. 27, 2023.
[cited by applicant]
Office Action as received in Korean application 10-2022-7015187 dated Nov. 1, 2022.
[cited by applicant]
Office Action as received in KR application 10-2023-7020481 dated Sep. 26, 2023.
[cited by applicant]
Notice of Allowance as received in KR application 10-2022-7015187 dated Apr. 14, 2023.
[cited by applicant]
Notice of Allowance as received in KR application 10-2023-7020481 dated Jan. 18, 2024.
[cited by applicant]
Office Action as received in Mexican application MX/a/2022/006095 dated Jun. 1, 2022 [No English translation available].
[cited by applicant]
Office Action as received in Mexican application MX/a/2022/006095 dated Apr. 5, 2024.
[cited by applicant]
Notice of Allowance as received in Philippines application 1-2022-550989 dated Dec. 7, 2023.
[cited by applicant]
Search Report and Written Opinion as received in SG application 11202113006V dated Dec. 4, 2023.
[cited by applicant]
Office Action as received in Taiwanese application 109117927 dated Jan. 9, 2023.
[cited by applicant]
Notice of Allowance as received in Taiwanese application 109117927 dated Oct. 12, 2023.
[cited by applicant]
Office Action as received in Thailand application 2201002725 dated Apr. 24, 2023.
[cited by applicant]
Search Report and Written Opinion as received in SG Application No. 11202203957S dated Feb. 7, 2024.
[cited by applicant]
U.S. Appl. No. 17/131,514, Mar. 3, 2021, Office Action.
[cited by applicant]
U.S. Appl. No. 17/131,514, Jun. 16, 2021, Office Action.
[cited by applicant]
U.S. Appl. No. 17/131,514, Dec. 6, 2021, Office Action.
[cited by applicant]
U.S. Appl. No. 17/131,514, Mar. 29, 2022, Notice of Allowance.
[cited by applicant]
U.S. Appl. No. 17/100,705, Apr. 21, 2021, Office Action.
[cited by applicant]
U.S. Appl. No. 17/100,705, Aug. 10, 2021, Notice of Allowance.
[cited by applicant]
U.S. Appl. No. 17/469,687, Apr. 13, 2022, Notice of Allowance.
[cited by applicant]
U.S. Appl. No. 17/469,680, Apr. 15, 2022, Office Action.
[cited by applicant]
U.S. Appl. No. 17/469,680, Jul. 15, 2022, Notice of Allowance.
[cited by applicant]
U.S. Appl. No. 17/812,315, Oct. 31, 2022, Office Action.
[cited by applicant]
U.S. Appl. No. 17/812,315, Feb. 1, 2023, Notice of Allowance.
[cited by applicant]
U.S. Appl. No. 17/660,165, Jul. 18, 2022, Office Action.
[cited by applicant]
U.S. Appl. No. 17/660,165, Nov. 3, 2022, Notice of Allowance.
[cited by applicant]
U.S. Appl. No. 17/660,170, Jul. 21, 2022, Office Action.
[cited by applicant]
U.S. Appl. No. 17/660,170, Nov. 8, 2022, Notice of Allowance.
[cited by applicant]
U.S. Appl. No. 18/047,196, Jan. 27, 2023, Office Action.
[cited by applicant]
U.S. Appl. No. 18/047,196, May 10, 2023, Office Action.
[cited by applicant]
U.S. Appl. No. 18/047,196, Oct. 13, 2023, Office Action.
[cited by applicant]
U.S. Appl. No. 18/047,196, Feb. 22, 2024, Office Action.
[cited by applicant]
U.S. Appl. No. 18/047,196, Mar. 29, 2024, Notice of Allowance.
[cited by applicant]
U.S. Appl. No. 18/047,545, Feb. 9, 2023, Office Action.
[cited by applicant]
U.S. Appl. No. 18/047,545, May 23, 2023, Office Action.
[cited by applicant]
U.S. Appl. No. 18/047,545, Oct. 12, 2023, Office Action.
[cited by applicant]
U.S. Appl. No. 18/047,545, Feb. 22, 2024, Office Action.
[cited by applicant]
U.S. Appl. No. 18/047,545, Apr. 4, 2024, Notice of Allowance.
[cited by applicant]
Notice of Acceptance as received in Australian application 2020284005 dated Aug. 29, 2024.
[cited by applicant]
Office Action as received in Chinese application 2023116995466 dated Aug. 17, 2024.
[cited by applicant]
Office Action as received in Chinese application 2023117065159 dated Aug. 21, 2024.
[cited by applicant]
Notice of Allowance as received in IL application 304041 dated Aug. 1, 2024.
[cited by applicant]
Lam et al: “The effect of continuous wavy micropatterns on silicone substrates on the alignment of skeletal muscle myoblasts and myotubes”, Biomaterials, Elsevier, Amsterdam, NL, vol. 27, No. 24, Aug. 1, 2006 (Aug. 1, 2…
[cited by applicant]
EPO Communication pursuant to Article 94(3) as received in application 20745342.4 dated Mar. 7, 2025.
[cited by applicant]
Notice of Allowance as received in IL application 319980 dated May 20, 2025.
[cited by applicant]
Notice of Allowance as received in Mexican application MX/a/2022/006095 dated May 14, 2025.
[cited by applicant]
Examination Report and Notice of Eligibility for Grant as received in SG Application No. 11202203957S dated Jul. 14, 2025.
[cited by applicant]
Examination Report as received in Australian application 2023200307 dated Jun. 16, 2025.
[cited by applicant]
Notice of Acceptance as received in Australian application 2023200307 dated Jun. 17, 2025.
[cited by applicant]
Second Office Action received in Canadian application 3,219,264 dated Jun. 26, 2025.
[cited by applicant]
Notice of Allowance as received in IL application 310833 dated Jun. 15, 2025.
[cited by applicant]
Notice of Allowance as received in IL application 321803 dated Aug. 12, 2025.
[cited by applicant]
U.S. Appl. No. 17/558,243, Jun. 30, 2025, Office Action.
[cited by applicant]
Examination Report and received in Canadian application 3,229,492 dated Aug. 7, 2025.
[cited by applicant]
Examination Report as received in Australian application 2023200307 dated Sep. 26, 2025.
[cited by applicant]
Examination Report as received in Australian application 2023200307 dated Feb. 16, 2026.
[cited by applicant]
Office Action as received in IL application 323083 dated Jan. 22, 2026.
[cited by applicant]
Office Action as received in IL application 323927 dated Mar. 16, 2026.
[cited by applicant]
Notice of Eligibility for Grant and Examination Report as received in SG application 11202502130U dated Mar. 4, 2026.
[cited by applicant]
Written Opinion as received in SG Application No. 10202402267S dated Mar. 31, 2026.
[cited by applicant]
U.S. Appl. No. 17/558,243, Jan. 14, 2026, Office Action.
[cited by applicant]
U.S. Appl. No. 18/060,322, Mar. 30, 2026, Office Action.
[cited by applicant]